Contraceptive use among U.S. women with HIV

Journal of Women's Health

Volumn 16, Issue 5, 2007, Pages 657-666

  Massad, L Stewart ^a   Evans, Charlesnika T ^b   Wilson, Tracey E ^c   Golub, Elizabeth T ^d   Sanchez Keeland, Lorraine ^e   Minkoff, Howard ^f   Weber, Kathleen ^g   Watts, D Heather ^h  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f MAIMONIDES MEDICAL CENTER   (United States)

^g Jr Hospital of Cook County   (United States)

^h EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; SPERMICIDAL AGENT;

ADULT; ARTICLE; BARRIER CONTRACEPTION; CD4 LYMPHOCYTE COUNT; CONTRACEPTION; FEMALE; FEMALE STERILIZATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; UNITED STATES; VIRUS TRANSMISSION;

ADULT; COHORT STUDIES; CONFIDENCE INTERVALS; CONTRACEPTION; CONTRACEPTION BEHAVIOR; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; QUESTIONNAIRES; SAFE SEX; UNITED STATES; UNSAFE SEX;

EID: 34447650072     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.0204     Document Type: Article

References (21)

1. Wang CC, McClelland RS, Overbaugh J, et al. The effect of hormonal contraception on genital tract shedding of HIV-1. AIDS 2004;18:205.
2. Lindsay MK, Grant J, Peterson HB, Willis S, Nelson P, Klein L. The impact of knowledge of human immunodeficiency virus serostatus on contraceptive choice and repeat pregnancy. Obstet Gynecol 1995;85:675.
3. Heard I, Potard V, Costagiliola D, Kazatchkine MD. Contraceptive use in HIV-positive women. J Acquir Immune Def Syndr 2004;36:714.
4. Belzer M, Rogers AS, Camarca M, et al., and the Adolescent Medicine HIV/AIDS Research Network. Contraceptive choices in HIV-infected and HIV at-risk adolescent females. J Adolesc Health 2001;29S:93.
5. Hankins C, Thang T, Lapointe N, for the Canadian Women's HIV Study Group. Sexual behavior and pregnancy outcome in HIV-infected women. J AIDS 1998;18:479.
6. Wilson TE, Massad LS, Riester KA, et al. The sexual, contraceptive and drug use behaviors of women with HIV and those at risk for infection: Results from the Women's Interagency HIV Study (WIHS). AIDS 1999;13:591.
7. Massad LS, Springer G, Jacobson L, et al. Pregnancy rates and predictors of conception, miscarriage and abortion: Results from the Women's Interagency HIV study. AIDS 2004;18:281.
8. De Vincenzi I, Jadand C, Couturier E, et al. Pregnancy and contraception in a French cohort of HIV-infected women. AIDS 1997;11:333.
9. Centers for Disease Control and Prevention. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR 1998;47(RR-5):1-82. Updated May 4, 2006. Available at aidsinfo.nih.gov/ guidelines/ Accessed June 1, 2006.
10. Massad LS, Farhi MS, Ackatz LE, Sha BE, Benson CA. Sexual behaviors of heterosexual women infected with HIV. J Womens Health 1995;4:681.
11. ACOG Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin No. 73: Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 2006;107:1453.
12. Barkan SE, Melnick SL, Martin-Preston S, et al The Women's Interagency HIV study. Epidemiology 1998;9:117.
13. Bacon M, von Wyl V, Alden C, et al. The Women's Interagency HIV study: An observational cohort brings clinical sciences to the bench. Clin Diag Lab Immunol 2005;12:1013.
14. Speroff L, Darney PD. A clinical guide for contraception, 4th ed. Philadelphia: Lippincott, Williams & Wilkins, 2005:5.
15. Clark RA, Theall K. Population-based study evaluating association between selected antiretroviral therapies and potential oral contraceptive failure. J AIDS 2004;37:1219.
16. Barbosa C, Macasaet M, Brockmann S, Sierra MF, Xia Z, Duerr A. Pelvic inflammatory disease and human immunodeficiency virus infection. Obstet Gynecol 1997;89:65.
17. Hoffman IF, Taha TE, Padian NS, et al. Nonoxynol-9 100 mg gel: Multi-site safety study from sub-Saharan Africa. AIDS 2004;18:2191.
18. Wilson TE, Minkoff H. Condom use consistency associated with beliefs regarding HIV disease transmission among women receiving HIV antiretroviral therapy. J AIDS 2001;27:289.
19. Centers for Disease Control and Prevention Adoption of protective behaviors among persons with recent HIV infection and diagnosis - Alabama, New Jersey, and Tennessee, 1997-1998. MMWR 2000;49:512.
20. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005;39:446.
21. Holtgrave DR, Curran JW. What works and what remains to be done in HIV prevention in the United States. Annu Rev Public Health 2006;27:261.